Our finding of increased thyroglobulin antibodies in 31% of participants with the highest PBDE body burdens is potentially of biologic significance because thyroglobulin antibodies are found in 80–90% of patients with chronic autoimmune thyroiditis and 50–60% of patients with Grave’s disease (Marcocci and Marino 2005). Here, TG is linked to Graves disease.